Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
Upadacitinib治疗银屑病关节炎长达3年的安全性:两项关键性3期试验的综合分析
期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-021-00410-z
Burmester, Gerd R; Winthrop, Kevin; Blanco, Ricardo; Nash, Peter; Goupille, Philippe; Azevedo, Valderilio F; Salvarani, Carlo; Rubbert-Roth, Andrea; Lesser, Elizabeth; Lippe, Ralph; Lertratanakul, Apinya; Mccaskill, Reva M; Liu, John; Ruderman, Eric M